BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9373456)

  • 1. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
    van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
    Gooren LJ; Giltay EJ; Bunck MC
    J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
    Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
    Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
    Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
    Asscheman H; Gooren LJ; Eklund PL
    Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone treatment of the adult transsexual patient.
    Gooren L
    Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Gooren LJ
    Am J Physiol; 1999 Feb; 276(2):E317-25. PubMed ID: 9950792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
    Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones.
    van Kesteren P; Lips P; Gooren LJ; Asscheman H; Megens J
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):347-54. PubMed ID: 9578826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
    Dittrich R; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):586-92. PubMed ID: 16320157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
    Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
    Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.
    Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Guillamon A
    J Sex Med; 2014 May; 11(5):1248-61. PubMed ID: 24617977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
    Ruetsche AG; Kneubuehl R; Birkhaeuser MH; Lippuner K
    Osteoporos Int; 2005 Jul; 16(7):791-8. PubMed ID: 15502960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.
    Colizzi M; Costa R; Pace V; Todarello O
    J Sex Med; 2013 Dec; 10(12):3049-58. PubMed ID: 23574768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects.
    Elbers JM; Giltay EJ; Teerlink T; Scheffer PG; Asscheman H; Seidell JC; Gooren LJ
    Clin Endocrinol (Oxf); 2003 May; 58(5):562-71. PubMed ID: 12699437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
    Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
    Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
    Slabbekoorn D; van Goozen SH; Megens J; Gooren LJ; Cohen-Kettenis PT
    Psychoneuroendocrinology; 1999 May; 24(4):423-47. PubMed ID: 10341369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.